3-(2-Bromophenyl)-9-phenyl-9H-carbazole, 98%, 250mg

7-FLUORO-3,4-DIHYDROQUINOLIN-2(1H)-ONE, 95.0%, 250mg

tert-Butyl 2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrrole-1-carboxylate, 95.0%, 10g

2'-(BIS(3,5-BIS(TRIFLUOROMETHYL)PHENYL)PHOSPHANYL)-3',6'-DIMETHOXY-N2,N2,N6,N6-TETRAMETHYL-[1,1'-BIPHENYL]-2,6-DIAMINE, 95%, 5g

Methyl 1-cyanocyclopentanecarboxylate, 95.0%, 5g

(2-Azabicyclo[2.1.1]Hexan-1-yl)methanol hydrochloride, 98%, 5g

4-(4-Nitrophenyl)morpholine, 95.0%, 1g

3,5-DIAMINO-4-METHYLBENZOIC ACID, 97.0%, 250mg

Phase separating paper MN 616 WA, 100 Piece(s)

Dimethylglyoxime disodium salt octahydrate, min. 98%, pa, 50 g, glass packaging

2-(4,5-Dichloro-1H-imidazol-1-yl)ethanethioamide, 95+%, 250mg

2-Bromo-4-chloroiodobenzene, 97.0%, 500g

2-(4-methoxyphenyl)imidazo[1,2-{a}]pyridin-3-amine, 95.0%, 500mg